Natco Pharma informs about press release

02 Sep 2021 Evaluate

Natco Pharma has informed that it enclosed a press release on 2nd September 2021 titled ‘Natco Pharma (Canada) Inc. announces the launch of PrNAT-LENALIDOMIDE Capsules, the first generic alternative to Revlimid®’ under Regulation 30 of SEBI (LODR) Regulations 2015.

The above information is a part of company’s filings submitted to BSE.

Natco Pharma Share Price

831.75 -2.10 (-0.25%)
23-Jan-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1631.65
Dr. Reddys Lab 1235.15
Cipla 1314.85
Zydus Lifesciences 881.95
Lupin 2137.15
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×